New trends in adjunctive treatment and diagnosis... (2020 study) Skip to main content
Review Journal of biological regulators and homeostatic agents 2020

New trends in adjunctive treatment and diagnosis in medication-related osteonecrosis of the jaw: A 10-year review.

De Santis D, Gelpi F, Luciano U, Zarantonello M, Poscolere A, Modena N, et al., Journal of biological regulators and homeostatic agents, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed ten years of published studies on add-on treatments used alongside standard care for medication-related osteonecrosis of the jaw (MRONJ), a bone condition linked to certain osteoporosis and cancer drugs.

What They Found

This literature review looked at how much research exists on several adjunctive treatments for MRONJ, including platelet concentrates (PRP, PRGF, PRF), hyperbaric oxygen (HBO), fluorescence-guided bone surgery, drugs like teriparatide or pentoxifylline with tocopherol, PET imaging, laser therapy, and ozone therapy. The abstract states the review's goal was to evaluate the quantity and quality of scientific studies on this topic, not to measure how well any treatment worked. No sample sizes, success rates, or other outcome figures are reported for any of these treatments, including HBO.

What This Means for Canadian Patients

This review does not show whether hyperbaric oxygen or any other adjunctive treatment improves outcomes for MRONJ. It only describes that these treatments have been studied to varying degrees, with the stated aim of assessing how much and how good that research is. Patients considering add-on therapies for MRONJ should know this abstract does not report whether any of them work.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a literature review, not original research, and by its own stated aim it evaluated only the quantity and quality of existing studies rather than reporting outcome data for any of the treatments it discusses.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 33541063
Year Published 2020
Journal Journal of biological regulators and homeostatic agents
MeSH Terms Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Humans; Laser Therapy; Tocopherols; Treatment Outcome

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology